{"id":"https://openalex.org/W2012840966","doi":"https://doi.org/10.1159/000195884","title":"Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer","display_name":"Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2012840966","doi":"https://doi.org/10.1159/000195884","mag":"2012840966","pmid":"https://pubmed.ncbi.nlm.nih.gov/19169046"},"language":"en","primary_location":{"id":"doi:10.1159/000195884","doi":"https://doi.org/10.1159/000195884","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000195884","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012989377","display_name":"Hendrik\u2010Tobias Arkenau","orcid":"https://orcid.org/0000-0002-2015-1549","observed_orcids":["https://orcid.org/0000-0002-2015-1549","https://orcid.org/0000-0003-0372-0540"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hendrik-Tobias Arkenau","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK. hendrik-tobias.arkenau@icr.ac.uk","Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK. hendrik-tobias.arkenau@icr.ac.uk","institution_ids":["https://openalex.org/I4210121186"]},{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017043037","display_name":"Andre Tesainer Brunetto","orcid":"https://orcid.org/0000-0002-7958-1279","observed_orcids":["https://orcid.org/0000-0002-7958-1279"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andre T. Brunetto","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060729173","display_name":"Jorge Barriuso","orcid":"https://orcid.org/0000-0002-5641-9105","observed_orcids":["https://orcid.org/0000-0002-5641-9105"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jorge Barriuso","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072116005","display_name":"David Olmos","orcid":"https://orcid.org/0000-0002-7003-4826","observed_orcids":["https://orcid.org/0000-0002-7003-4826"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Olmos","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Eaton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Eaton","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann de Bono","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053304892","display_name":"Ian Robert Judson","orcid":"https://orcid.org/0000-0002-4766-5304","observed_orcids":["https://orcid.org/0000-0002-4766-5304"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ian Judson","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, London and Surrey, UK","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014804968","display_name":"Stan B. Kaye","orcid":"https://orcid.org/0000-0003-3318-8575","observed_orcids":["https://orcid.org/0000-0003-3318-8575"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stan Kaye","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3306,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.80622896,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"76","issue":"3","first_page":"151","last_page":"156"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-colorectal-cancer","display_name":"advanced colorectal cancer","score":1.0},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7519999742507935},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7300000190734863},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.9629999995231628},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.7760000228881836},{"id":"https://openalex.org/keywords/treatment-refractory-cancer","display_name":"treatment-refractory cancer","score":0.6209999918937683},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.7789999842643738},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.8700000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9083905220031738},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7901011109352112},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7177110910415649},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6641170978546143},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.654168426990509},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.6298792958259583},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.6025198101997375},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5538811683654785},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.47899767756462097},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.46364155411720276},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4472110867500305},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4222254455089569},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41428062319755554}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1159/000195884","doi":"https://doi.org/10.1159/000195884","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000195884","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},{"id":"pmid:19169046","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19169046","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1335887","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1335887/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ONCOLOGY , 76 (3) pp. 151-156. (2009)","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1566518481","https://openalex.org/W1580788756","https://openalex.org/W1969875009","https://openalex.org/W1979300931","https://openalex.org/W2007742741","https://openalex.org/W2014718897","https://openalex.org/W2014745585","https://openalex.org/W2042724509","https://openalex.org/W2085705101","https://openalex.org/W2097121246","https://openalex.org/W2107249415","https://openalex.org/W2107866135","https://openalex.org/W2121368761","https://openalex.org/W2128447158","https://openalex.org/W2133399075","https://openalex.org/W2139248078","https://openalex.org/W2141157727","https://openalex.org/W2142564546","https://openalex.org/W2151955362","https://openalex.org/W2156575195","https://openalex.org/W2157416388","https://openalex.org/W2157769714","https://openalex.org/W2168739610","https://openalex.org/W2171492233","https://openalex.org/W2227477053","https://openalex.org/W2409420104","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2088286383","https://openalex.org/W4281844401","https://openalex.org/W2896909095","https://openalex.org/W2908427159","https://openalex.org/W2955450919","https://openalex.org/W2042076422","https://openalex.org/W2089005472","https://openalex.org/W2242478447","https://openalex.org/W2009857409","https://openalex.org/W160400900"],"abstract_inverted_index":{"BACKGROUND:":[0],"Standard":[1],"treatment":[2],"for":[3,65,169],"patients":[4,50,68,133,170,179],"with":[5,14,35,148,171,180],"advanced":[6],"colorectal":[7],"cancer":[8,195],"(ACRC)":[9],"includes":[10],"fluoropyrimidines":[11],"in":[12,192],"combination":[13],"oxaliplatin":[15],"or":[16],"irinotecan.":[17],"The":[18,89],"addition":[19],"of":[20,102,131,153,178,200],"targeted":[21],"agents":[22],"such":[23],"as":[24,136],"bevacizumab":[25],"and":[26,48,85,111,121,129,143,197],"cetuximab":[27],"to":[28,160,207],"these":[29,209],"chemotherapy":[30],"backbones":[31],"further":[32],"improved":[33],"outcome":[34,64],"survival":[36,110,113],"rates.":[37],"However,":[38],"even":[39],"after":[40],"intensive":[41],"treatment,":[42],"most":[43],"tumors":[44],"will":[45],"subsequently":[46],"progress":[47],"some":[49],"are":[51],"offered":[52],"experimental":[53],"phase":[54,73,193],"I":[55,74,194],"therapies.":[56],"PATIENTS":[57],"AND":[58],"METHODS:":[59],"We":[60],"retrospectively":[61],"analyzed":[62],"the":[63,77,107,132,198,201],"78":[66],"ACRC":[67,181],"treated":[69],"consecutively":[70],"within":[71],"23":[72],"trials":[75],"at":[76,141],"Royal":[78],"Marsden":[79],"Hospital":[80],"(RMH)":[81],"between":[82],"January":[83,86],"2004":[84],"2008.":[87],"RESULTS:":[88],"median":[90,99,108],"age":[91],"was":[92],"62":[93],"years":[94],"(range":[95,105],"26-78).":[96],"After":[97],"a":[98],"follow-up":[100],"time":[101],"21.4":[103],"weeks":[104,117,123,155,162],"1.7-115.6)":[106],"progression-free":[109],"overall":[112],"(OS)":[114],"were":[115,134],"8.6":[116],"(95%":[118,124,156,163],"CI:":[119,125,157,164],"6.4-10.7)":[120],"29.1":[122],"15.7-42.5),":[126],"respectively.":[127,146],"28.8":[128],"8.2%":[130],"assessed":[135],"having":[137],"stable":[138],"disease":[139],"(SD)":[140],"3":[142],"6":[144],"months,":[145],"Patients":[147],"SD":[149],"had":[150],"an":[151],"OS":[152],"40.6":[154],"32.9-48.2)":[158],"compared":[159],"17.4":[161],"14.0-20.8,":[165],"p":[166],"=":[167],"0.017)":[168],"progressive":[172],"disease.":[173],"CONCLUSION:":[174],"A":[175],"limited":[176],"number":[177],"who":[182],"failed":[183],"conventional":[184],"treatments":[185],"can":[186,205],"derive":[187],"clinical":[188],"benefit":[189],"by":[190],"participating":[191],"trials,":[196],"use":[199],"RMH":[202],"prognostic":[203],"score":[204],"help":[206],"identify":[208],"patients.":[210]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}